Fijian families are increasingly burdened with the responsibility of purchasing basic medical supplies, including intravenous (IV) fluids, for their loved ones receiving treatment in hospitals. This situation persists despite the Ministry of Health’s repeated assurances of no national shortage of these essential supplies. The disparity between the government’s claims and the harsh reality experienced by patients and medical staff has led to public outrage, prompting many to demand accountability and swift action from the government.
One poignant example comes from Ms. Archana Prasad, who shared her family’s experience of having to buy IV fluids for her sister-in-law in the ICU, amidst rising dengue cases. She lamented the lack of refunds for purchased supplies, a sentiment echoed by many. The International Women’s Association (IWA) has also stepped in, delivering saline solutions to children’s hospitals like the Colonial War Memorial Hospital in Suva to address these gaps left by the health system’s shortages.
While the Ministry did acknowledge global supply pressures, which are projected to persist until 2025, it continues to assert that Fiji’s stock levels are sufficient. Minister for Finance Biman Prasad stated that recent shipments included 3,000 units of saline, with another 4,200 units pending clearance. However, on the front lines, healthcare providers including the Fiji Medical Association highlight that many hospitals continue to face dangerously low stock levels, compelling patients to resort to private pharmacies to obtain fluids.
Opposition MP Premila Kumar has raised pertinent concerns regarding the clarity of these supply levels, questioning why patients should need to procure IV fluids during a time of crisis. The ongoing dengue outbreak amplifies the urgency of these issues, revealing significant operational failures within the healthcare system that need immediate attention.
Amidst the frustrating backdrop, there appears to be a glimmer of hope for reform. Experts and advocates for change are calling for a reformation in the procurement processes to enhance the reliability and efficiency of healthcare supply chains. This crisis may ultimately serve as a catalyst for the necessary improvements in Fiji’s healthcare system.
As various stakeholders collaborate to find solutions, there is potential for meaningful advancements that could lead to a more resilient healthcare system in Fiji. Engaging the community, improving transparency, and fostering partnership could provide a pathway to ensure that all Fijians receive the essential medical care they need without financial burden.
Leave a comment